Garra do Diabo Herbarium
Harpagophytum procumbens 200 mg
45 coated tablets
DEVIL’S CLAW – Harpagophytum procumbens 200 mg. INDICATIONS: Treatment of rheumatic diseases and degenerative disorders of the locomotor system, such as arthritis and arthrosis, and treatment of low back pain. CONTRAINDICATIONS: Pregnancy, lactation, children and in patients with stomach or duodenal ulcer and gastritis. Hypersensitivity to any of the components of the formula. WARNINGS: In case of hypersensitivity to the product, it is recommended to discontinue use and consult a physician. DRUG INTERACTIONS: Devil's claw may interact with drugs used to treat cardiac disorders, such as antiarrhythmic drugs and hypotensive/hypertensive therapy. ADVERSE REACTIONS: Headaches, tinnitus, loss of appetite and taste. Gastrointestinal disorders may occur in sensitive people. POSOLOGY: Take 1 tablet two to three times daily. In elderly patients half the dose or ¾ of recommended adult dose should be administered. Prolonged treatments should have medical attention. MS: 1.1860.0035. SOLD UNDER MEDICAL PRESCRIPTION.
Harpagophytum procumbens | Its name comes from the aspect of the branchy, woody fruit with claw-like beards. The plant was commonly used by native Africans in the form of infusion, rheumatic diseases and other pathologies. Although it had been botanical knowledge since the nineteenth century, it was only after World War I initially in Germany that studies on its pharmacological properties were developed. Devil’s claw develops in relatively limited areas of Africa, especially in the Kalihari Desert and the Namibian steppes.1,2
References: 1 – Kathe W, Barsch F, Honnef S. Trade in Devil’s Claw (Harpagophytum procumbens) in Germany – Status, Trends and Certification. The Food and Agriculture Organisation of the United Nations. 2003. 2 – Introdução à fitoterapia: utilizando adequadamente as plantas medicinais. Colombo: Herbarium Lab. Bot. Ltda, 2008.